Short title: Colchicine responsive chronic recurrent multifocal osteomyelitis with MEFV mutations Key message: The MEFV gene might be associated with more than typical FMF.
Sir, Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by self-limited recurrent attacks of fever with serositis such as peritonitis, pleuritis and arthritis [1] . FMF is caused by mutations in MEFV gene [2] . This gene had been considered to be responsible only for FMF in the past, however, recent reports show that MEFV gene is associated with more than typical FMF and is linked to additional clinical presentations within the family of the autoinflammatory diseases [2] [3] [4] .
Here, we describe a case of colchicine responsive chronic recurrent multifocal osteomyelitis (CRMO) with MEFV gene mutations.
A 14-year-old female was referred with fever of unknown origin persisting for 15 days. FMF is an autosomal recessive, inherited periodic inflammatory syndrome, characterized by self-limited recurrent attacks of fever with serositis such as peritonitis, pleuritis and arthritis [1] . The disease is common among people coming from eastern Mediterranean ancestry. The mainstay of treatment is cochicine which is effective for both relieving symptoms and preventing secondary amyloidosis. MEFV gene encodes a protein named pyrin, which is expressed in neutrophils and monocytes. The function of pyrin is still unknown and remains to be determined.
MEFV gene had been considered to be responsible only for FMF in the past. However, about one-third of patients with FMF have a single mutation on one allele. This finding suggests that FMF might be transferred as an autosomal dominant trait with partial penetration. Another possibility is that an additional, unidentified gene might be associated with the disease in these patients with single allele mutation.
Recently it has been reported a case with heterozygous MEFV mutations and distinct clinical presentations not typical for FMF, colchicine responsive recurrent episodes of muscle pains [3] . These reports including our case show MEFV gene is associated with more than a single disease (FMF) and is linked to additional clinical presentations within the family of the autoinflammatory diseases [4, 5] and some rheumatic diseases such as s-JIA [6, 7] .
The mutation analysis in our patient demonstrated the heterozygous mutation of E148Q-P369S-R408Q. In the whole list of 186 sequence alterations reported in Infevers -an online database for autoinflammatory mutations available at http://fmf.igh.cnrs.fr/ISSAID/infevers [8] , this mutation is reported to be associated with atypical clinical presentations for FMF.
CRMO is an ill-defined inflammatory disease. In typical cases, multiple bone lesions with apparent bone destruction, hyperostosis and pustulosis of the skin are seen [9] .
But there are variable clinical manifestations, which make differential diagnosis of CRMO often difficult. LPIN2 mutation is detectable in a syndrome form of CRMO known as Majeed syndrome [10] , but for most cases responsible gene is unknown.
CRMO is unusual, or unexpected manifestation for FMF, and this is the first case of CRMO with MEFV mutations to our knowledge. To start the treatment with colchicines promptly, thereby relieving symptoms and preventing secondary amyloidosis, the mutation analysis of MEFV gene should be performed in cases of CRMO.
